eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2022
vol. 24
 
Share:
Send email
Share:
abstract:
Original paper

Evaluation of the effectiveness of a mobile application on the adherence of patients with atrial fibrillation

GANI TULEPBERGENOV
1
,
DINARA OSPANOVA
2
,
SAIRA ALIMBAYEVA
1
,
ARAS PUODZIUKYNAS
3
,
ALMAT KODASBAYEV
1
,
ALIYA ABENOVA
1
,
AIZHAN ALMUKHANOVA
1
,
SHYNAR TANABAYEVA
1
,
ILDAR FAKHRADIYEV
1
,
ALTYNAY SADYKOVA
4

  1. S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  2. Al-Farabi Kazakh National University, Almaty, Kazakhstan
  3. Lithuanian University of Health Sciences, Kaunas, Lithuania
  4. Scientific Centre of Paediatrics and Children’s Surgery, Almaty, Kazakhstan
Family Medicine & Primary Care Review 2022; 24(3): 275–283
DOI: https://doi.org/10.5114/fmpcr.2022.118289
Online publish date: 2022/10/03
View full text Get citation
 
PlumX metrics:
Background
To date, no research on the adherence of patients with atrial fibrillation (AF) within the territory of Kazakhstan and Central Asia has been conducted.

Objectives
The study aimed to investigate the effect of a mobile application on adherence in patients diagnosed with AF and treated in outpatient clinics. In addition, the reliability of a structured scale for assessing adherence in patients with atrial fibrillation was also validated.

Material and methods
A prospective one-centre study was conducted on 599 patients diagnosed with AF at the City Cardiology Centre (Almaty, Kazakhstan). Patients were sub-divided into control (CG) and intervention (IG) groups. Patients in the IG group used the MyTherapy mobile app. Treatment adherence was assessed using the 14-item Lebanese Drug Adherence Scale (LMAS-14). Data was collected before starting therapy (T1) and 3 months (T2), 6 months (T3) and 12 months (T4) after the start of treatment.

Results
In the T1 period, the adherence of patients in the CG and IG groups was average (p = 0.547). After 3 months (T2), adherence of participants in the IG group (39.1 ± 1.3) was significantly higher than in the CG group (p ≤ 0.05). In the T3 period, patients of the IG group had a high adherence equal to 38.3 ± 1.6 (p ≤ 0.05). After 12 months (T4), the respondents in the IG group retained high adherence rates equal to 38.9 ± 3.2 (p = 0.001). An estimate of the readmission rate within 12 months shows relatively low rates in the IG group (9.8%).

Conclusions
The results of the study showed the effectiveness of using the MyTherapy mobile app for increasing adherence in patients with AF. In addition, the use of the LMAS-14 facilitated and optimised the assessment of the level of adherence in patients with AF.

keywords:

atrial fibrillation, cardiology, mobile applications, patients

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.